Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Nat Med ; 3(3): 287-92, 1997 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9055855

RESUMEN

Human herpesvirus-8 (HHV-8) has been detected in Kaposi's sarcoma (KS) lesions of all types (AIDS-related, classical and endemic), in body-cavity-based B-cell lymphomas (BCBLs) and in lesions of multicentric Castleman's disease (MCD). We have identified a major gamma-herpesvirus-divergent locus (DL-B) in HHV-8 DNA encoding several HHV-8 unique open reading frames (ORFs), including a homologue of interleukin-6 (IL-6) and two homologues of macrophage inflammatory protein MIP-1. We show that the HHV-8-encoded IL-6 homologue (vIL-6) shares functional properties with endogenous IL-6 proteins and that both vIL-6 and vMIP-1 transcripts are present at high levels following butyrate induction of an HHV-8' BCBL cell line. Low amounts of constitutive vIL-6, but not vMIP-1, mRNA were also detected. The presence of a functional IL-6 homologue encoded by HHV-8 may provide a mechanistic model for the hypothesized role of HHV-8 in KS, MCD and BCBL that involves the mitogenic effects of vIL-6 on surrounding cells. MIP-1 proteins may enhance these effects through the chemotactic recruitment of endogenous cytokine-producing cells into affected tissues and could potentially influence HIV disease progression in coinfected individuals through interactions with the HIV co-receptor CCR-5.


Asunto(s)
ADN Viral/genética , Herpesvirus Humano 8/genética , Interleucina-6/genética , Proteínas Inflamatorias de Macrófagos/genética , Secuencia de Aminoácidos , Quimiocina CCL4 , Humanos , Datos de Secuencia Molecular , ARN Mensajero/análisis , Análisis de Secuencia de ADN , Homología de Secuencia de Aminoácido
2.
J Parasitol ; 79(5): 653-62, 1993 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8410535

RESUMEN

A polymerase chain reaction (PCR)-based approach is being employed to study RNA transcripts in malarial parasites, a system that is not easily amenable to molecular studies. Our aim is to compare messages from different life cycle stages to determine whether regulatory information is encoded in the structure of plasmodial transcripts as a result of differential RNA processing. In particular, we have analyzed the structure of the message encoding the circumsporozoite (CS) protein of the murine malaria Plasmodium berghei, the immunodominant surface antigen of the infectious stage of the parasite. Our major findings are that a subset of the CS message utilizes multiple polyadenylation sites, that some processed CS transcripts are found in blood-stage parasites, and that the 5' untranslated region of the message is unusually long and has multiple start sites. Moreover, repetitive motifs that may represent enhancers or transcriptional binding sites are present upstream of the transcription unit. In addition, we describe details of the cDNA-directed PCR procedure that may be helpful to other parasitologists who work with small, unpurified biological samples.


Asunto(s)
Plasmodium berghei/genética , Reacción en Cadena de la Polimerasa , Proteínas Protozoarias/genética , ARN Protozoario/genética , Transcripción Genética , Actinas/genética , Empalme Alternativo , Animales , ADN Protozoario/química , Regulación de la Expresión Génica , Proteínas Protozoarias/biosíntesis , Proteínas Protozoarias/química , Procesamiento Postranscripcional del ARN , ARN Protozoario/química , ARN Protozoario/metabolismo
3.
Leukemia ; 27(6): 1358-68, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23247046

RESUMEN

Nur77 and Nor1 are highly conserved orphan nuclear receptors. We have recently reported that nur77(-/-)nor1(-/-) mice rapidly develop acute myeloid leukemia (AML) and that Nur77 and Nor1 transcripts were universally downregulated in human AML blasts. These findings indicate that Nur77 and Nor1 function as leukemia suppressors. We further demonstrated silencing of Nur77 and Nor1 in leukemia stem cells (LSCs). We here report that inhibition of histone deacetylase (HDAC) using the specific class I HDAC inhibitor SNDX-275 restored the expression of Nur77/Nor1 and induced expression of activator protein 1 transcription factors c-Jun and JunB, and of death receptor TRAIL, in AML cells and in CD34(+)/38(-) AML LSCs. Importantly, SNDX-275 induced extensive apoptosis in AML cells, which could be suppressed by silencing nur77 and nor1. In addition, pro-apoptotic proteins Bim and Noxa were transcriptionally upregulated by SNDX-275 in AML cells and in LSCs. Our present work is the first report of a novel mechanism of HDAC inhibitor-induced apoptosis in AML that involves restoration of the silenced nuclear receptors Nur77 and Nor1, activation of activator protein 1 transcription factors, a death receptor and pro-apoptotic proteins.


Asunto(s)
Antineoplásicos/farmacología , Benzamidas/farmacología , Silenciador del Gen , Inhibidores de Histona Desacetilasas/farmacología , Proteínas de Transporte de Membrana/genética , Miembro 1 del Grupo A de la Subfamilia 4 de Receptores Nucleares/genética , Piridinas/farmacología , Apoptosis , Secuencia de Bases , Western Blotting , Cartilla de ADN , Citometría de Flujo , Humanos , Leucemia Mieloide Aguda/genética , Leucemia Mieloide Aguda/patología , Células Madre Neoplásicas/patología
4.
Leukemia ; 25(11): 1711-7, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21660042

RESUMEN

The regulation of protein kinase B (AKT) is a dynamic process that depends on the balance between phosphorylation by upstream kinases for activation and inactivation by dephosphorylation by protein phosphatases. Phosphorylated AKT is commonly found in acute myeloid leukemia (AML) and confers an unfavorable prognosis. Understanding the relative importance of upstream kinases and AKT phosphatase in the activation of AKT is relevant for the therapeutic targeting of this signaling axis in AML. The B55α subunit of protein phosphatase 2A (PP2A) has been implicated in AKT dephosphorylation, but its role in regulating AKT in AML is unknown. We examined B55α protein expression in blast cells derived from 511 AML patients using reverse phase protein analysis. B55α protein expression was lower in AML cells compared with normal CD34+ cells. B55α protein levels negatively correlated with threonine 308 phosphorylation levels. Low levels of B55α were associated with shorter complete remission duration, demonstrating that decreased expression is an adverse prognostic factor in AML. These findings suggest that decreased B55α expression in AML is at least partially responsible for increased AKT signaling in AML and suggests that therapeutic targeting of PP2A could counteract this.


Asunto(s)
Leucemia Mieloide Aguda/fisiopatología , Proteína Fosfatasa 2/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Inducción de Remisión , Perfilación de la Expresión Génica , Humanos , Leucemia Mieloide Aguda/enzimología , Fosforilación , Proteína Fosfatasa 2/genética
5.
Leukemia ; 22(4): 808-18, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18200035

RESUMEN

Raf/MEK/Erk signaling is activated in the majority of acute myeloid leukemias (AMLs), providing rationale for targeting this pathway with therapeutic intent. We investigated growth-inhibitory and proapoptotic effects of sorafenib in AML. Our studies demonstrated that sorafenib significantly inhibited the phosphorylation levels of Raf downstream target proteins MEK1/2 and Erk, induced apoptosis and inhibited colony formation in AML cell lines and in primary AML samples. Mechanistically, treatment with sorafenib resulted in upregulation of proapoptotic Bim, accompanied by an increase in Bad, Bax and Bak protein levels and decreased Mcl-1, X-linked inhibitor of apoptosis and surviving levels, which mainly led to the activation of the intrinsic apoptotic pathway. Silencing of Bim protein expression significantly abrogated sorafenib-induced apoptosis, suggesting a critical function of Bim in the activation of the intrinsic mitochondrial pathway induced by sorafenib. Importantly, sorafenib also modulated phospho-Erk, Bim, Bax and Mcl-1 levels in samples procured from patients in an ongoing Phase I clinical trial of sorafenib in AML. Combination of sorafenib with cytarabine or the novel small molecule Bcl-2 inhibitor ABT-737 synergistically induced cell death in AML cell lines. Our results strongly suggest potential activity of sorafenib as a novel mechanism-based therapeutic agent in AML.


Asunto(s)
Proteínas Reguladoras de la Apoptosis/metabolismo , Apoptosis/efectos de los fármacos , Bencenosulfonatos/farmacología , Leucemia Mieloide Aguda/tratamiento farmacológico , Proteínas de la Membrana/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Piridinas/farmacología , Transducción de Señal/efectos de los fármacos , Proteínas Reguladoras de la Apoptosis/análisis , Proteínas Reguladoras de la Apoptosis/efectos de los fármacos , Proteína 11 Similar a Bcl2 , Línea Celular , Sinergismo Farmacológico , Humanos , Leucemia Mieloide Aguda/patología , Mitocondrias/metabolismo , Niacinamida/análogos & derivados , Compuestos de Fenilurea , Sorafenib
6.
J Gen Virol ; 77 ( Pt 8): 1901-12, 1996 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8760442

RESUMEN

Human herpesvirus 7 (HHV-7) is a recently isolated herpesvirus that has been shown to be related to human cytomegalovirus and human herpesvirus 6 and to be a member of the betaherpesvirus subgroup. Here we report the cloning, restriction endonuclease mapping and partial sequence analysis of HHV-7 strain JI DNA. Virus particles were obtained from the supernatant of infected SupT1 cells, the DNA isolated by proteinase K treatment-phenol extraction, and full-length viral DNA was purified and isolated on a pulsed-field gel. Aliquots of this highly purified material were treated in the following ways: (i) sonicated and end-repaired to create short randomly sheared fragments for cloning into M13mp 18-Smal vector DNA; (ii) cut with EcoRI for cloning into EcoRI-cut lambda ZAPII or lambda DASHII vectors; (iii) cut with BamHI for cloning into BamHI-cut lambda ZAP-Express or lambda DASHII vectors. Partial nucleotide sequencing of the M13 clones followed by detection of open reading frames and their translation allowed the identification of homologues through FASTA searches of the database. Relevant M13 clones were used as probes to isolate corresponding lambda phage clones, which could tentatively be mapped to the genome on the basis of presumed genetic collinearity between HHV-7 and HHV-6. Genomic "walking' between EcoRI and BamHI lambda genomic libraries enabled overlapping neighbouring clones to be identified and mapped. Each of these clones was analysed to map BamHI, EcoRI, Sa/l, Smal and Xhol restriction endonuclease sites to provide complete endonuclease maps for the entire genome.


Asunto(s)
Genoma Viral , Herpesvirus Humano 7/genética , Secuencia de Aminoácidos , Bacteriófago lambda/genética , Clonación Molecular , Sondas de ADN , Vectores Genéticos , Humanos , Datos de Secuencia Molecular , Secuencias Repetitivas de Ácidos Nucleicos , Mapeo Restrictivo , Células Tumorales Cultivadas
7.
J Virol ; 69(12): 8041-5, 1995 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7494318

RESUMEN

Human herpesvirus 6 (HHV-6) and HHV-7 are closely related T-lymphotropic betaherpesviruses which share a common genomic organization and are composed of a single unique component (U) that is bounded by direct repeats (DRL and DRR). In HHV-6, a sequences have been identified at each end of the DR motifs, resulting in the arrangement aDRLa-U-aDRRa. In order to determine whether determine whether HHV-7 contains similar a sequences, we have sequenced the DRL-U and U-DRR junctions of HHV-7 strain JI, together with the DRR.DRL junction from the head-to-tail concatamer that is generated during productive virus infection. In addition, we have sequenced the genomic termini of an independent isolate of HHV-7. As in HHV-6, a (GGGTTA)n motif identical to the human telomeric repeat sequence (TRS) was identified adjacent to, but not at, the genome termini of HHV-7. The left genome terminus and the U-DRR junction contained a homolog of the consensus herpesvirus packaging signal, pac-1, followed by short tandem arrays of TRSs separated by single copies of a second 6-bp repeat. This organization is similar to the arrangement found at U-DRR in HHV-6 but differs from it in that the TRS arrays are considerably shorter in HHV-7. The right genome terminus and the DRL-U junction contained a homolog of the consensus herpesvirus packaging signal, pac-2, followed by longer tandem arrays of TRSs separated by single copies of either a 6-bp or a 14-bp repeat. This arrangement is considerably more complex than the simple tandem array of TRSs that is present at the corresponding genomic location in HHV-6 and corresponds to a site of both inter- and intrastrain heterogeneity in HHV-7. The presence of TRSs in lymphotropic herpesviruses from humans (HHV-6 and HHV-7), horse (equine herpesvirus 2), and birds (Marek's disease virus) is striking and suggests that these sequences may have functional or structural significance.


Asunto(s)
Genoma Viral , Herpesvirus Humano 7/genética , Secuencias Repetitivas de Ácidos Nucleicos , Telómero , Secuencia de Bases , Herpesvirus Humano 6/genética , Humanos , Datos de Secuencia Molecular , Homología de Secuencia de Ácido Nucleico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA